GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 91 filers reported holding GENERATION BIO CO in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $404,397 | -78.9% | 102,900 | -71.6% | 0.02% | -78.5% |
Q3 2022 | $1,921,000 | -81.3% | 361,824 | -76.7% | 0.08% | -84.1% |
Q2 2022 | $10,273,000 | -50.1% | 1,556,032 | -44.5% | 0.50% | -39.7% |
Q1 2022 | $20,574,000 | +1437.7% | 2,802,950 | +1382.7% | 0.82% | +1579.6% |
Q4 2021 | $1,338,000 | – | 189,050 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,279,484 | $35,601,781 | 4.82% |
GREAT POINT PARTNERS LLC | 1,022,537 | $4,396,909 | 0.86% |
Artal Group S.A. | 2,814,191 | $12,101 | 0.72% |
PFM Health Sciences, LP | 2,648,297 | $11,387,677 | 0.50% |
SVB FINANCIAL GROUP | 40,401 | $173,724 | 0.33% |
SECTORAL ASSET MANAGEMENT INC | 385,070 | $1,655,801 | 0.32% |
Yiheng Capital Management, L.P. | 1,601,766 | $6,887,594 | 0.27% |
EcoR1 Capital, LLC | 1,956,579 | $8,413,290 | 0.27% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,194,522 | 0.23% |
Bellevue Group AG | 3,620,280 | $15,567,204 | 0.23% |